• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续性柯萨奇 B 病毒感染与 1 型糖尿病的发病机制。

Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus.

机构信息

Laboratoire de Virologie ULR3610, Université de Lille, CHU Lille, Lille, France.

出版信息

Nat Rev Endocrinol. 2022 Aug;18(8):503-516. doi: 10.1038/s41574-022-00688-1. Epub 2022 Jun 1.

DOI:10.1038/s41574-022-00688-1
PMID:35650334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9157043/
Abstract

Enteroviruses are believed to trigger or accelerate islet autoimmunity in genetically susceptible individuals, thereby resulting in loss of functional insulin-producing β-cells and type 1 diabetes mellitus (T1DM). Although enteroviruses are primarily involved in acute and lytic infections in vitro and in vivo, they can also establish a persistent infection. Prospective epidemiological studies have strongly associated the persistence of enteroviruses, especially coxsackievirus B (CVB), with the appearance of islet autoantibodies and an increased risk of T1DM. CVB can persist in pancreatic ductal and β-cells, which leads to structural or functional alterations of these cells, and to a chronic inflammatory response that promotes recruitment and activation of pre-existing autoreactive T cells and β-cell autoimmune destruction. CVB persistence in other sites, such as the intestine, blood cells and thymus, has been described; these sites could serve as a reservoir for infection or reinfection of the pancreas, and this persistence could have a role in the disturbance of tolerance to β-cells. This Review addresses the involvement of persistent enterovirus infection in triggering islet autoimmunity and T1DM, as well as current strategies to control enterovirus infections for preventing or reducing the risk of T1DM onset.

摘要

肠病毒被认为在遗传易感个体中引发或加速胰岛自身免疫,从而导致功能性胰岛素产生β细胞的丧失和 1 型糖尿病(T1DM)。尽管肠病毒主要参与体外和体内的急性和裂解感染,但它们也可以建立持续性感染。前瞻性流行病学研究强烈表明,肠病毒,特别是柯萨奇病毒 B(CVB)的持续存在与胰岛自身抗体的出现和 T1DM 的风险增加有关。CVB 可在胰腺导管和β细胞中持续存在,导致这些细胞的结构或功能改变,并引发慢性炎症反应,促进先前存在的自身反应性 T 细胞的募集和激活以及β细胞自身免疫破坏。已经描述了 CVB 在其他部位(如肠道、血细胞和胸腺)的持续存在;这些部位可能是胰腺感染或再感染的储库,这种持续存在可能在破坏对β细胞的耐受性方面发挥作用。本综述讨论了持续性肠病毒感染在引发胰岛自身免疫和 T1DM 中的作用,以及目前控制肠病毒感染以预防或降低 T1DM 发病风险的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bd/9157043/e1f5cae43de1/41574_2022_688_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bd/9157043/67eba4876664/41574_2022_688_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bd/9157043/a294b1c1d188/41574_2022_688_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bd/9157043/e1f5cae43de1/41574_2022_688_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bd/9157043/67eba4876664/41574_2022_688_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bd/9157043/a294b1c1d188/41574_2022_688_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3bd/9157043/e1f5cae43de1/41574_2022_688_Fig3_HTML.jpg

相似文献

1
Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus.持续性柯萨奇 B 病毒感染与 1 型糖尿病的发病机制。
Nat Rev Endocrinol. 2022 Aug;18(8):503-516. doi: 10.1038/s41574-022-00688-1. Epub 2022 Jun 1.
2
[Coxsackievirus B infection and pathogenesis of type 1 diabetes].[柯萨奇病毒B感染与1型糖尿病的发病机制]
Virologie (Montrouge). 2022;26(6):415-430. doi: 10.1684/vir.2022.0976.
3
Enterovirus persistence as a mechanism in the pathogenesis of type 1 diabetes.肠道病毒持续感染作为1型糖尿病发病机制之一
Discov Med. 2014 Nov;18(100):273-82.
4
Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host.1 型糖尿病发病机制:肠道病毒与宿主的相互作用。
Nat Rev Endocrinol. 2010 May;6(5):279-89. doi: 10.1038/nrendo.2010.27. Epub 2010 Mar 30.
5
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention.柯萨奇病毒与 1 型糖尿病:致糖尿病机制及预防意义。
Endocr Rev. 2023 Jul 11;44(4):737-751. doi: 10.1210/endrev/bnad007.
6
Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes.B 组柯萨奇病毒与自身免疫:关注 1 型糖尿病。
Expert Rev Clin Immunol. 2011 May;7(3):357-66. doi: 10.1586/eci.11.11.
7
Coxsackievirus B Tailors the Unfolded Protein Response to Favour Viral Amplification in Pancreatic β Cells.柯萨奇病毒 B 使未折叠蛋白反应适应于在胰腺 β 细胞中促进病毒扩增。
J Innate Immun. 2019;11(4):375-390. doi: 10.1159/000496034. Epub 2019 Feb 20.
8
Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes.柯萨奇病毒B4在1型糖尿病发病机制中的作用。
Diabetes Metab. 2008 Dec;34(6 Pt 1):537-48. doi: 10.1016/j.diabet.2008.05.008. Epub 2008 Oct 31.
9
Enteroviruses as causative agents in type 1 diabetes: loose ends or lost cause?肠道病毒作为 1 型糖尿病的致病因子:未解决的问题还是没有希望的原因?
Trends Endocrinol Metab. 2014 Dec;25(12):611-9. doi: 10.1016/j.tem.2014.08.002. Epub 2014 Aug 28.
10
Coxsackievirus B4 can infect human pancreas ductal cells and persist in ductal-like cell cultures which results in inhibition of Pdx1 expression and disturbed formation of islet-like cell aggregates.柯萨奇病毒 B4 可感染人胰腺导管细胞,并在类似导管的细胞培养物中持续存在,导致 Pdx1 表达抑制和胰岛样细胞聚集形成紊乱。
Cell Mol Life Sci. 2013 Nov;70(21):4169-80. doi: 10.1007/s00018-013-1383-4. Epub 2013 Jun 18.

引用本文的文献

1
Enterovirus A71 priorities, challenges, and future opportunities in humoral immunity and vaccine development.肠道病毒A71在体液免疫和疫苗研发方面的重点、挑战及未来机遇
NPJ Vaccines. 2025 Aug 15;10(1):194. doi: 10.1038/s41541-025-01184-z.
2
Construction of enterovirus G expressing reporter genes for antiviral drug screening assays.构建用于抗病毒药物筛选试验的表达报告基因的肠道病毒G
BMC Vet Res. 2025 Aug 13;21(1):515. doi: 10.1186/s12917-025-04960-0.
3
Selected strains of the Ganoderma lucidum complex from Finnish forests have excellent broadly acting antiviral properties.

本文引用的文献

1
Fighting Enteroviral Infections to Prevent Type 1 Diabetes.对抗肠道病毒感染以预防1型糖尿病。
Microorganisms. 2022 Apr 1;10(4):768. doi: 10.3390/microorganisms10040768.
2
When therapeutic drugs lead to diabetes.当治疗药物导致糖尿病时。
Diabetologia. 2022 May;65(5):751-762. doi: 10.1007/s00125-022-05666-w. Epub 2022 Mar 4.
3
Improved genetic risk scoring algorithm for type 1 diabetes prediction.改良的 1 型糖尿病预测遗传风险评分算法。
从芬兰森林中挑选出的灵芝复合体菌株具有出色的广谱抗病毒特性。
Sci Rep. 2025 Jul 2;15(1):23565. doi: 10.1038/s41598-025-08377-5.
4
Monkeypox virus and type 1 diabetes: a molecular insight into inflammatory signaling and β-cell autoimmunity.猴痘病毒与1型糖尿病:对炎症信号传导和β细胞自身免疫的分子洞察
Virol J. 2025 Jun 14;22(1):195. doi: 10.1186/s12985-025-02822-7.
5
Metformin as antiviral therapy protects hyperglycemic and diabetic patients.二甲双胍作为抗病毒疗法可保护高血糖和糖尿病患者。
mBio. 2025 Jun 11;16(6):e0063425. doi: 10.1128/mbio.00634-25. Epub 2025 May 20.
6
The Role of Infant and Early Childhood Gut Virome in Immunity and the Triggering of Autoimmunity-A Narrative Review.婴幼儿肠道病毒组在免疫及自身免疫触发中的作用——一篇综述
Diagnostics (Basel). 2025 Feb 8;15(4):413. doi: 10.3390/diagnostics15040413.
7
No Increased Risk of Hepatitis B Virus Infection in Patients with Celiac Disease: A Population-Based Study.乳糜泻患者感染乙型肝炎病毒的风险未增加:一项基于人群的研究。
Dig Dis Sci. 2025 Apr;70(4):1521-1529. doi: 10.1007/s10620-025-08878-3. Epub 2025 Feb 21.
8
Review of organ damage from COVID and Long COVID: a disease with a spectrum of pathology.新冠病毒感染及新冠长期症状引发的器官损伤综述:一种具有多种病理表现的疾病
Med Rev (2021). 2024 Jul 2;5(1):66-75. doi: 10.1515/mr-2024-0030. eCollection 2025 Feb.
9
β-Cell Deletion of Hypoxia-Inducible Factor 1α (HIF-1α) Increases Pancreatic β-Cell Susceptibility to Streptozotocin.缺氧诱导因子1α(HIF-1α)在胰腺β细胞中的缺失增加了β细胞对链脲佐菌素的敏感性。
Int J Mol Sci. 2024 Dec 15;25(24):13451. doi: 10.3390/ijms252413451.
10
A novel microRNA promotes coxsackievirus B4 infection of pancreatic β cells.一种新型微小RNA促进柯萨奇病毒B4对胰腺β细胞的感染。
Front Immunol. 2024 Dec 4;15:1414894. doi: 10.3389/fimmu.2024.1414894. eCollection 2024.
Pediatr Diabetes. 2022 May;23(3):320-323. doi: 10.1111/pedi.13310. Epub 2022 Jan 19.
4
Dynamic changes in immune gene co-expression networks predict development of type 1 diabetes.免疫基因共表达网络的动态变化可预测 1 型糖尿病的发生。
Sci Rep. 2021 Nov 22;11(1):22651. doi: 10.1038/s41598-021-01840-z.
5
Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database.巴瑞替尼治疗类风湿关节炎的安全性:中位 4.6 年和长达 9.3 年的治疗的最终结果:来自长期扩展研究和综合数据库的结果。
Ann Rheum Dis. 2022 Mar;81(3):335-343. doi: 10.1136/annrheumdis-2021-221276. Epub 2021 Oct 27.
6
Localization of enteroviral RNA within the pancreas in donors with T1D and T1D-associated autoantibodies.在 T1D 及 T1D 相关自身抗体供者的胰腺中肠病毒 RNA 的定位。
Cell Rep Med. 2021 Aug 17;2(8):100371. doi: 10.1016/j.xcrm.2021.100371.
7
Characterisation of enterovirus RNA detected in the pancreas and other specimens of live patients with newly diagnosed type 1 diabetes in the DiViD study.在 DiViD 研究中,对新诊断为 1 型糖尿病的活患者胰腺和其他标本中检测到的肠道病毒 RNA 进行了特征描述。
Diabetologia. 2021 Nov;64(11):2491-2501. doi: 10.1007/s00125-021-05525-0. Epub 2021 Aug 14.
8
Coxsackievirus B4 Transplacental Infection Severely Disturbs Central Tolerogenic Mechanisms in the Fetal Thymus.柯萨奇病毒B4经胎盘感染严重扰乱胎儿胸腺中的中枢耐受机制。
Microorganisms. 2021 Jul 19;9(7):1537. doi: 10.3390/microorganisms9071537.
9
Viruses and Type 1 Diabetes: From Enteroviruses to the Virome.病毒与1型糖尿病:从肠道病毒到病毒组
Microorganisms. 2021 Jul 16;9(7):1519. doi: 10.3390/microorganisms9071519.
10
Investigation of the utility of the 1.1B4 cell as a model human beta cell line for study of persistent enteroviral infection.研究 1.1B4 细胞作为一种人类β细胞系模型在持续性肠道病毒感染研究中的应用。
Sci Rep. 2021 Aug 2;11(1):15624. doi: 10.1038/s41598-021-94878-y.